Skip to main content
Erschienen in: Journal of Cancer Education 1/2015

01.03.2015

Factors Influencing the Attitudes of Chinese Cancer Patients and Their Families Toward the Disclosure of a Cancer Diagnosis

verfasst von: Wenwen Sun, Zhehai Wang, Shu Fang, Minmin Li

Erschienen in: Journal of Cancer Education | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

The disclosure of a cancer diagnosis to patients has been a core topic in oncology departments. Previous studies have demonstrated that Chinese cancer patients and their families differ in their attitudes toward cancer diagnosis disclosure. However, the influencing factors regarding their different attitudes remain unknown. In the present study, a questionnaire was delivered to 266 cancer patients and 266 matched family members. The results showed that cancer patients were more likely to desire to be informed of their condition than family members (85 vs. 18 %, P < 0.01). The patients’ age had a significant influence on their attitudes (P < 0.01), while the family members’ gender, profession, educational level, and their relationship with the patients could significantly affect their attitudes (all P < 0.05). Further multivariate analyses indicated that a family member’s gender (odds ratio (OR) = 2.928, 95 % confidence interval (CI) 1.379–6.213, P = 0.005), profession (OR = 2.814, 95 % CI 1.548–5.119, P = 0.001), and educational level (OR = 0.105, 95 % CI 0.053–0.211, P < 0.001) remained significant variables. Due to a lower educational level, only 74 % of families knew about chemotherapy, and 90 % of families were not familiar with molecular targeted therapy. However, 78 % of patients expected to be cured of their cancer, 16.5 % expected to reduce the severity of their condition, and 4.9 % expected to lengthen their lives. Therefore, physicians have a responsibility to appropriately provide knowledge regarding cancer to the patients’ families if their educational level is lower and if they have no knowledge of recent treatments, which may improve their acceptability of a cancer diagnosis for patients.
Literatur
1.
Zurück zum Zitat Zamanzadeh V, Rahmani A, Valizadeh L, Ferguson C, Hassankhani H, Nikanfar AR, Howard F (2013) The taboo of cancer: the experiences of cancer disclosure by Iranian patients, their family members and physicians. Psychooncology 22:396–402PubMed Zamanzadeh V, Rahmani A, Valizadeh L, Ferguson C, Hassankhani H, Nikanfar AR, Howard F (2013) The taboo of cancer: the experiences of cancer disclosure by Iranian patients, their family members and physicians. Psychooncology 22:396–402PubMed
2.
Zurück zum Zitat Li J, Gao XH, Yang XM, Jing P, Yu SY (2012) Whether, when, and who to disclose bad news to patients with cancer: a survey in 150 pairs of hospitalized patients with cancer and family members in China. Psychooncology 21:778–784CrossRefPubMed Li J, Gao XH, Yang XM, Jing P, Yu SY (2012) Whether, when, and who to disclose bad news to patients with cancer: a survey in 150 pairs of hospitalized patients with cancer and family members in China. Psychooncology 21:778–784CrossRefPubMed
3.
Zurück zum Zitat Valizadeh L, Zamanzadeh V, Rahmani A, Howard F, Nikanfar AR, Ferguson C (2012) Cancer disclosure: experiences of Iranian cancer patients. Nurs Health Sci 14:250–256CrossRefPubMed Valizadeh L, Zamanzadeh V, Rahmani A, Howard F, Nikanfar AR, Ferguson C (2012) Cancer disclosure: experiences of Iranian cancer patients. Nurs Health Sci 14:250–256CrossRefPubMed
4.
Zurück zum Zitat Mystakidou K, Parpa E, Tsilika E, Katsouda E, Vlahos L (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154CrossRefPubMed Mystakidou K, Parpa E, Tsilika E, Katsouda E, Vlahos L (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer 12:147–154CrossRefPubMed
5.
Zurück zum Zitat Tse C, Chong A, Fok S (2003) Breaking bad news: a Chinese perspective. Palliat Med 17:339–343CrossRefPubMed Tse C, Chong A, Fok S (2003) Breaking bad news: a Chinese perspective. Palliat Med 17:339–343CrossRefPubMed
6.
Zurück zum Zitat Spiegel W, Zidek T, Maier M, Vutuc C, Isak K, Karlic H, Micksche M (2009) Breaking bad news to cancer patients: survey and analysis. Psychooncology 18:179–186CrossRefPubMed Spiegel W, Zidek T, Maier M, Vutuc C, Isak K, Karlic H, Micksche M (2009) Breaking bad news to cancer patients: survey and analysis. Psychooncology 18:179–186CrossRefPubMed
7.
Zurück zum Zitat Grassi L, Giraldi T, Messina E, Magnani K, Valle E, Cartei G (2000) Physicians’ attitudes to and problems with truth-telling to cancer patients. Support Care Cancer 8:40–45PubMed Grassi L, Giraldi T, Messina E, Magnani K, Valle E, Cartei G (2000) Physicians’ attitudes to and problems with truth-telling to cancer patients. Support Care Cancer 8:40–45PubMed
8.
Zurück zum Zitat Del Pozo PR, Fins JJ, Helmy I, El Chaki R, El Shazly T, Wafaradi D, Mahfoud Z (2012) Truth-telling and cancer diagnoses: physician attitudes and practices in Qatar. Oncologist 17:1469–1474CrossRef Del Pozo PR, Fins JJ, Helmy I, El Chaki R, El Shazly T, Wafaradi D, Mahfoud Z (2012) Truth-telling and cancer diagnoses: physician attitudes and practices in Qatar. Oncologist 17:1469–1474CrossRef
9.
Zurück zum Zitat Jiang Y, Li J-Y, Liu C et al (2006) Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer 14:1119–1125CrossRefPubMed Jiang Y, Li J-Y, Liu C et al (2006) Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer 14:1119–1125CrossRefPubMed
10.
Zurück zum Zitat Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psychooncology 16:928–936CrossRefPubMed Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psychooncology 16:928–936CrossRefPubMed
11.
Zurück zum Zitat Laxmi S, Khan JA (2013) Does the cancer patient want to know? Results from a study in an Indian tertiary cancer center. South Asian J Cancer 2:57CrossRefPubMedCentralPubMed Laxmi S, Khan JA (2013) Does the cancer patient want to know? Results from a study in an Indian tertiary cancer center. South Asian J Cancer 2:57CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Wang D-C, Peng X, Guo C-B, Su Y-J (2013) When clinicians telling the truth is de facto discouraged, what is the family’s attitude towards disclosing to a relative their cancer diagnosis? Support Care Cancer 21:1089–1095CrossRefPubMed Wang D-C, Peng X, Guo C-B, Su Y-J (2013) When clinicians telling the truth is de facto discouraged, what is the family’s attitude towards disclosing to a relative their cancer diagnosis? Support Care Cancer 21:1089–1095CrossRefPubMed
13.
Zurück zum Zitat Yun YH, Lee CG, Kim S-Y et al (2004) The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 22:307–314CrossRefPubMed Yun YH, Lee CG, Kim S-Y et al (2004) The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 22:307–314CrossRefPubMed
14.
Zurück zum Zitat Keam B, Yun YH, Heo DS et al (2013) The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives. Support Care Cancer 1–8 Keam B, Yun YH, Heo DS et al (2013) The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives. Support Care Cancer 1–8
15.
Zurück zum Zitat Nwankwo K, Anarado AN, Ezeome E (2012) Attitudes of cancer patients in a university teaching hospital in southeast Nigeria on disclosure of cancer information. Psychooncology Nwankwo K, Anarado AN, Ezeome E (2012) Attitudes of cancer patients in a university teaching hospital in southeast Nigeria on disclosure of cancer information. Psychooncology
16.
Zurück zum Zitat Liu W-D, Zhao H-J, Ma J-L (2009) Analysis of cancer incidence in 2005 in Linqu County, Shandong Province [J]. China Cancer 3:006 Liu W-D, Zhao H-J, Ma J-L (2009) Analysis of cancer incidence in 2005 in Linqu County, Shandong Province [J]. China Cancer 3:006
17.
Zurück zum Zitat Sun J-D, Guo X-L, Li W-K (2007) Estimating the burden of malignant neoplasm in Shandong Province. Chin Health Econ 8:023 Sun J-D, Guo X-L, Li W-K (2007) Estimating the burden of malignant neoplasm in Shandong Province. Chin Health Econ 8:023
18.
Zurück zum Zitat Yun YH, Kwon YC, Lee MK et al (2010) Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol 28:1950–1957CrossRefPubMed Yun YH, Kwon YC, Lee MK et al (2010) Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol 28:1950–1957CrossRefPubMed
19.
Zurück zum Zitat Mystakidou K, Tsilika E, Parpa E, Katsouda E, Vlahos L (2005) Patterns and barriers in information disclosure between health care professionals and relatives with cancer patients in Greek society. Eur J Cancer Care (Engl) 14:175–181CrossRef Mystakidou K, Tsilika E, Parpa E, Katsouda E, Vlahos L (2005) Patterns and barriers in information disclosure between health care professionals and relatives with cancer patients in Greek society. Eur J Cancer Care (Engl) 14:175–181CrossRef
20.
Zurück zum Zitat Montazeri A (2013) Cancer disclosure, health-related quality of life, and psychological distress: an Iranian perspective. New Challenges in Communication with Cancer Patients. Springer. p. 403–409 Montazeri A (2013) Cancer disclosure, health-related quality of life, and psychological distress: an Iranian perspective. New Challenges in Communication with Cancer Patients. Springer. p. 403–409
21.
22.
Zurück zum Zitat Bozcuk H, Erdoğan V, Eken C, Ciplak E, Samur M, Ozdoğan M, Savaş B (2002) Does awareness of diagnosis make any difference to quality of life? Support Care Cancer 10:51–57CrossRefPubMed Bozcuk H, Erdoğan V, Eken C, Ciplak E, Samur M, Ozdoğan M, Savaş B (2002) Does awareness of diagnosis make any difference to quality of life? Support Care Cancer 10:51–57CrossRefPubMed
23.
Zurück zum Zitat Thorne SE, Bultz BD, Baile WF (2005) Is there a cost to poor communication in cancer care?: a critical review of the literature. Psychooncology 14:875–884CrossRefPubMed Thorne SE, Bultz BD, Baile WF (2005) Is there a cost to poor communication in cancer care?: a critical review of the literature. Psychooncology 14:875–884CrossRefPubMed
24.
Zurück zum Zitat Thorne S, Oliffe JL, Stajduhar KI (2013) Communicating shared decision-making: cancer patient perspectives. Patient Educ Couns 90:291–296CrossRefPubMed Thorne S, Oliffe JL, Stajduhar KI (2013) Communicating shared decision-making: cancer patient perspectives. Patient Educ Couns 90:291–296CrossRefPubMed
25.
Zurück zum Zitat Lin C-C, Tsai H-F, Chiou J-F, Lai Y-H, Kao C-C, Tsou T-S (2003) Changes in levels of hope after diagnostic disclosure among Taiwanese patients with cancer. Cancer Nurs 26:155–160CrossRefPubMed Lin C-C, Tsai H-F, Chiou J-F, Lai Y-H, Kao C-C, Tsou T-S (2003) Changes in levels of hope after diagnostic disclosure among Taiwanese patients with cancer. Cancer Nurs 26:155–160CrossRefPubMed
26.
Zurück zum Zitat Winterling J, Wasteson E, Glimelius B, Sjödén P-O, Nordin K (2004) Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses. Cancer Nurs 27:381–388CrossRefPubMed Winterling J, Wasteson E, Glimelius B, Sjödén P-O, Nordin K (2004) Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses. Cancer Nurs 27:381–388CrossRefPubMed
27.
Zurück zum Zitat Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z, Omidvari S (2007) Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol 7:28CrossRefPubMedCentralPubMed Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z, Omidvari S (2007) Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol 7:28CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N (2004) Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer 12:161–167CrossRefPubMed Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N (2004) Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer 12:161–167CrossRefPubMed
29.
Zurück zum Zitat Seo M, Tamura K, Shijo H, Morioka E, Ikegame C, Hirasako K (2000) Telling the diagnosis to cancer patients in Japan: attitude and perception of patients, physicians and nurses. Palliat Med 14:105–110CrossRefPubMed Seo M, Tamura K, Shijo H, Morioka E, Ikegame C, Hirasako K (2000) Telling the diagnosis to cancer patients in Japan: attitude and perception of patients, physicians and nurses. Palliat Med 14:105–110CrossRefPubMed
30.
Zurück zum Zitat Sasako M (1992) Telling the diagnosis of cancer. Igaku no Ayumi 160:146–151 Sasako M (1992) Telling the diagnosis of cancer. Igaku no Ayumi 160:146–151
31.
Zurück zum Zitat Spiegel D, Morrow GR, Classen C et al (1999) Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psychooncology 8:482–493CrossRefPubMed Spiegel D, Morrow GR, Classen C et al (1999) Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psychooncology 8:482–493CrossRefPubMed
33.
Zurück zum Zitat Elwyn TS, Fetters MD, Sasaki H, Tsuda T (2002) Responsibility and cancer disclosure in Japan. Soc Sci Med 54:281–293CrossRefPubMed Elwyn TS, Fetters MD, Sasaki H, Tsuda T (2002) Responsibility and cancer disclosure in Japan. Soc Sci Med 54:281–293CrossRefPubMed
34.
Zurück zum Zitat Khalil RB (2013) Attitudes, beliefs and perceptions regarding truth disclosure of cancer-related information in the Middle East: a review. Palliat Support Care 1:1–10 Khalil RB (2013) Attitudes, beliefs and perceptions regarding truth disclosure of cancer-related information in the Middle East: a review. Palliat Support Care 1:1–10
35.
Zurück zum Zitat Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311CrossRefPubMed Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311CrossRefPubMed
36.
Zurück zum Zitat Schuricht F, Nestoriuc Y (2013) The placebo and nocebo effects in cancer treatment. Psychological Aspects of Cancer. Springer. p. 309–326 Schuricht F, Nestoriuc Y (2013) The placebo and nocebo effects in cancer treatment. Psychological Aspects of Cancer. Springer. p. 309–326
37.
Zurück zum Zitat Mohan R, Beydoun H, Barnes-Ely ML, Lee L, Davis JW, Lance R, Schellhammer P (2009) Patients’ survival expectations before localized prostate cancer treatment by treatment status. J Am Board Fam Med 22:247–256CrossRefPubMed Mohan R, Beydoun H, Barnes-Ely ML, Lee L, Davis JW, Lance R, Schellhammer P (2009) Patients’ survival expectations before localized prostate cancer treatment by treatment status. J Am Board Fam Med 22:247–256CrossRefPubMed
Metadaten
Titel
Factors Influencing the Attitudes of Chinese Cancer Patients and Their Families Toward the Disclosure of a Cancer Diagnosis
verfasst von
Wenwen Sun
Zhehai Wang
Shu Fang
Minmin Li
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 1/2015
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0687-x

Weitere Artikel der Ausgabe 1/2015

Journal of Cancer Education 1/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.